Long-term cost-effectiveness of Oncotype DX® versus current clinical practice from a Dutch cost perspective

This study analyzes the incremental cost-effectiveness of Oncotype DX(®) testing to support adjuvant chemotherapy recommendations, versus current clinical practice, for patients with estrogen receptor-positive (ER(+)), node-negative or micrometastatic (pN1mic) early-stage breast cancer in The Nether...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of comparative effectiveness research 2015-09, Vol.4 (5), p.433-445
Hauptverfasser:	Kip, Michelle, Monteban, Helma, Steuten, Lotte
Format:	Artikel
Sprache:	eng
Schlagworte:	Breast Neoplasms - diagnosis Breast Neoplasms - drug therapy Breast Neoplasms - economics Chemotherapy, Adjuvant - economics Cost-Benefit Analysis - economics Cost-Benefit Analysis - statistics & numerical data Female Gene Expression Profiling - economics Humans Markov Chains Middle Aged Neoplasm Recurrence, Local - diagnosis Neoplasm Recurrence, Local - economics Netherlands Predictive Value of Tests Quality-Adjusted Life Years Survival Analysis Time
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!